NSB vs VIT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NSB

NEUROSCIEN FPO [NSB]

49LOW

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

NSB VIT
Technical
49
53
Catalyst
53
51
Sentiment
50
50
Fundamental
87
76
Momentum
36
28
Risk Gate
46
45

Key Metrics

NSB Metric VIT
$27.7MMarket Cap$18.6M
301KAvg Volume (20d)682K
N/AShort InterestN/A
$0.26052-Week High$0.075
$0.05552-Week Low$0.021
-4.2%Daily Change+3.6%
$0.068Reference Price$0.029
-29.6%ROE+1.2%
N/AProfit Margin+0.6%

Active Signals

NSB Signals

●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)
●Very high P/S ratio (87.0x)
●Strong revenue growth (+129%)

VIT Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.1x)
●Moderate revenue growth (+8%)
●Near 52-week low (13% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare NSB and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs PAR →ACW vs IPD →IPD vs LTP →ACW vs PAR →LTP vs PAR →
NSB Full Analysis → VIT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).